Recurrent reversible dilated cardiomyopathy secondary to viral and streptococcal pneumonia vaccine-associated myocarditis

Cardiology in Review

Volumn 14, Issue 4, 2006, Pages

  Makaryus, Amgad N ^a   Revere, David J ^a   Steinberg, Bart ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Dilated cardiomyopathy; Vaccine associated myocarditis; Viral myocarditis

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INFLUENZA VACCINE; INOTROPIC AGENT; STREPTOCOCCUS VACCINE; VIRUS VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; LABORATORY TEST; MYOCARDITIS; PHYSICAL EXAMINATION; STREPTOCOCCUS PNEUMONIA; VACCINATION; VIRUS PNEUMONIA; PATHOPHYSIOLOGY; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; VIROLOGY;

AGED; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; INFLUENZA VACCINES; MYOCARDITIS; PNEUMOCOCCAL VACCINES; RECURRENCE; RESPIRATORY TRACT INFECTIONS;

EID: 33746302497     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000174803.68564.65     Document Type: Article

References (16)

1. Mason JW. Myocarditis. Adv Intern Med. 1999;44:293.
2. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076.
3. Boccara F, Benhaiem-Sigaux N, Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest. 2001;120:671-672.
4. Saurina G, Shirazi S, Lane JM, et al. Myocarditis after smallpox vaccination: a case report. Clin Infect Dis. 2003;37:145-146.
5. Cassimatis DC, Atwood JE, Engler R, et al. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol. 2004;43:1503-1510.
6. Eckert RE. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol. 2004;44:201-205.
7. Bowles NE, Towbin JA. Molecular aspects of myocarditis. Curr Opin Cardiol. 1998;13:179-184.
8. Kandolf R, Canu A, Hofschneider PH. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol. 1985;17:167.
9. Chow LH, Gauntt CJ, McManus BM. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab Invest. 1991;64:55.
10. Kandolf R, Klingel K, Zell R, et al. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology. 1993;35:140.
11. Takehana H, Inomata T, Kuwao S, et al. Recurrent fulminant viral myocarditis with a short clinical course. Circ J. 2003;67:646-648.
12. Bowles NE. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466-472.
13. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388-1397.
14. O'Connell JB, Mason JW, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis: the myocarditis treatment trial investigators. N Engl J Med. 1995;333:269-275.
15. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis natural history and treatment. N Engl J Med. 1997;336:1860-1866.
16. Pisani B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med. 1997;102:459-469.